Patent details

91222 Product Name: "Alendronate Sodium/Colecalciferol et ses dérivés pharmaceutiquement acceptables (FOSAVANCE®)"

Basic Information

Publication number:
91222
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP989357520
Legal Status:
Lapsed
Application number:
91222
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
EU/1/05/310/001-005
Marketing Authorization Type:
Marketing Authorization Date:
24/08/2005
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
EU/1/05/310/001-005
Marketing Authorization Type:
Marketing Authorization Date:
24/08/2005
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
15/02/2006
First Marketing Authorization date:
24/08/2005
Grant date:
18/04/2006
Activation date:
Publication date:
18/04/2006
Lapsed date:
17/07/2018
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
24/08/2020
SPC Extension Expiration:
24/08/2020
Rejection date:
Withdrawal date:

Owner

From:
15/02/2006
 
 

Name:
MERCK & CO., INC.
Address:
EAST LINCOLN AVENUE 126, 07065, RAHWAY, N.J., United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
15/02/2006
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
DAIFOTIS Anastasia, G.
Address:
United States (US)

2

Name:
SANTORA Arthur, C., II
Address:
United States (US)

3

Name:
YATES A., John
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages